Other · Synthetic tetrapeptide studied as a peptide bioregulator
Bronchogen
Also known as AEDL; Ala-Glu-Asp-Leu
The AEDL tetrapeptide, investigated in bronchial epithelial models without an established receptor target.
- Length
- 4 amino acids
- Half-life
- Not well characterised
- Mechanism
- Bronchogen has been investigated for effects on gene expression and cellular differentiation in bronchial epithelial models. A specific receptor and a validated direct molecular target have not been established.
- Studied in
- Reported experimental work examines bronchial epithelial cultures and animal respiratory-tissue models, with endpoints including epithelial morphology and gene-expression markers.
About Bronchogen
Bronchogen is the synthetic tetrapeptide Ala-Glu-Asp-Leu, conventionally abbreviated AEDL. It belongs to a group of short peptides described in the peptide-bioregulator literature and associated with tissue-focused experimental programmes. Its name reflects investigation in bronchial systems, not demonstrated selective delivery to those tissues. Although this literature developed partly from work on tissue peptide preparations, the defined synthetic sequence should not automatically be equated with a uniquely identified endogenous signalling molecule.
Research descriptions focus on epithelial-cell characteristics, gene-expression patterns and experimental changes in respiratory tissues. These observations do not establish a receptor-mediated pathway, and claims of direct sequence-specific regulation of DNA require dedicated binding and functional evidence. A useful laboratory assessment would distinguish broad responses to culture conditions from reproducible peptide-dependent changes. Independent replication, sequence-matched controls and clear reporting of peptide purity are especially important when interpreting this relatively limited mechanistic literature.
Laboratory notes
- Confirm AEDL identity and terminal chemistry by mass spectrometry; record counterion and peptide-content information separately from chromatographic purity.
- Control medium pH and vehicle composition when comparing expression or morphology endpoints.
- Use a composition-matched scrambled sequence and monitor cell number to distinguish expression changes from altered culture composition.
Storage and reconstitution basics: storage guide.
Questions about Bronchogen
Does the name demonstrate bronchial tissue selectivity?
No. The name reflects the research context; selective binding, uptake or distribution requires separate experimental evidence.
Is there an established Bronchogen receptor?
No specific receptor is established sufficiently to describe AEDL as a selective receptor agonist or antagonist.
Can transcriptional changes demonstrate direct DNA binding?
No. Expression changes may be indirect. Direct binding requires appropriate biophysical assays, specificity controls and functional validation.
Is Bronchogen for human use?
No. It is supplied strictly for in-vitro laboratory research and is not for human or animal consumption.
Related research peptides
All products are sold for laboratory research use only. Not for human consumption, not a medicine, not for diagnosing, treating or preventing any condition.